Management of tenosynovial giant cell tumour of the foot and ankle.

Geert SpierenburgSarah Tamar LancasterLizz van der HeijdenMonique J L MastboomHans GelderblomSarah PratapMichiel A J van de SandeC L Max H Gibbons

Published in: The bone & joint journal (2021)

We recommend open surgical excision as the primary treatment for TGCT of the foot and ankle, particularly in patients with Dt-TGCT with extra-articular involvement. Severe osteochondral destruction may justify salvage procedures, although these are not often undertaken. Systemic treatment is indicated for unresectable or refractory cases. However, side effects are commonly experienced, and relapses may occur once treatment has ceased. Cite this article: Bone Joint J 2021;103-B(4):788-794.

Keyphrases

giant cell
minimally invasive
early onset
combination therapy
body composition
soft tissue
replacement therapy